Non-vitamin K antagonist anticoagulants to cardioembolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice
Fuente:
Redalyc
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Faculdade de Medicina de Jundiaí
2016
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1876453349823348736 |
|---|---|
| author | Ivan Aprahamian |
| author_facet | Ivan Aprahamian |
| contents | Non-vitamin K antagonist anticoagulants to cardioembolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice Ivan Aprahamian Nayara L. Froio Richard Murdoch Montgomery Elias David-Neto Medicina non warfarin Ischemic stroke anticoagulation vitamin K antagonists anticoagulants Stroke is one of the most important disease and cause of mortality worldwide. Several clinical scenarios demand full dose of anticoagulants after stroke or to the treatment of some frequent comorbidity, namely most i m p o r t a n t t h e a t r i a l f i b r i l l a t i o n . Anticoagulation is intended both to primary and secondary prevention in stroke. However, controversy exists over many issues regarding mainly to type of agent, efficacy according to etiology, ideal time of anticoagulation and the use of novel anticoagulants. This latter consists mostly on the use of non-vitamin antagonists oral anticoagulants. 2016 artículo científico 0100-2929 https://www.redalyc.org/articulo.oa?id=243246722007 en http://www.redalyc.org/revista.oa?id=2432 Perspectivas Médicas application/pdf Faculdade de Medicina de Jundiaí Perspectivas Médicas (Brasil) Num.1 Vol.27 |
| format | Artículo científico |
| id | redalyc_243246722007 |
| institution | Redalyc |
| language | en |
| publishDate | 2016 |
| publisher | Faculdade de Medicina de Jundiaí |
| spellingShingle | Non-vitamin K antagonist anticoagulants to cardioembolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice Ivan Aprahamian Medicina non warfarin Ischemic stroke anticoagulation vitamin K antagonists anticoagulants Non-vitamin K antagonist anticoagulants to cardioembolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice Ivan Aprahamian Nayara L. Froio Richard Murdoch Montgomery Elias David-Neto Medicina non warfarin Ischemic stroke anticoagulation vitamin K antagonists anticoagulants Stroke is one of the most important disease and cause of mortality worldwide. Several clinical scenarios demand full dose of anticoagulants after stroke or to the treatment of some frequent comorbidity, namely most i m p o r t a n t t h e a t r i a l f i b r i l l a t i o n . Anticoagulation is intended both to primary and secondary prevention in stroke. However, controversy exists over many issues regarding mainly to type of agent, efficacy according to etiology, ideal time of anticoagulation and the use of novel anticoagulants. This latter consists mostly on the use of non-vitamin antagonists oral anticoagulants. 2016 artículo científico 0100-2929 https://www.redalyc.org/articulo.oa?id=243246722007 en http://www.redalyc.org/revista.oa?id=2432 Perspectivas Médicas application/pdf Faculdade de Medicina de Jundiaí Perspectivas Médicas (Brasil) Num.1 Vol.27 |
| title | Non-vitamin K antagonist anticoagulants to cardioembolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice |
| topic | Medicina non warfarin Ischemic stroke anticoagulation vitamin K antagonists anticoagulants |
| url | https://www.redalyc.org/articulo.oa?id=243246722007 |